Safety and Efficacy of Intranasal and Topical Mupirocin in Eradicating Colonization With Staphylococcus Aureus (SA) in Critically Ill Infants - a Phase 2, Multi-Center, Open Label, Randomized Trial
Condition: Staphylococcal InfectionInterventions: Drug: Mupirocin calcium; Drug: Mupirocin calciumSponsor: National Institute of Allergy and Infectious Diseases (NIAID)Recruiting - verified December 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Allergy | Allergy & Immunology | Calcium | Infectious Diseases | Mupirocin | Research | Staphylococcus Aureus